Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis
Rheumatology, clinical testing, immunology, rheumatoid arthritis
Amplio Pharma has reported phase 1b results for NovoBioJect, an investigational combination of low-dose methotrexate (MTX) and novobiocin being developed …
Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial
October 6, 2026Diabetes, GLP-1, Obesity, diabetes, obesity, phase 3 trial
Boehringer Ingelheim’s investigational survodutide produced weight loss of up to 13.1% after 76 weeks in people with obesity or overweight …
ESTEVE CDMO adds $17.5m to Illinois expansion
October 6, 2026Clinical trials supplies & documentation logistics, Logistics & Distribution, Manufacturing and Production, Warehousing & distribution API manufacture, Corporate, Pharmacy, investment, laboratory, pharma production
ESTEVE CDMO is investing a further $17.5m to expand capacity and containment capabilities at its Morton Grove facility in Illinois, …
AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials
October 4, 2026Asthma & COPD, COPD, asthma, clinical trials, monoclonal antibodies
AstraZeneca’s tozorakimab reduced moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) in two phase 3 trials, cutting exacerbation …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
October 4, 2026Biopharmaceuticals, Pharmacy, cell culture, manufacturing
Brenntag Pharma and dsm-firmenich have entered a long-term global distribution partnership covering GMP-grade vitamins for biopharmaceutical manufacturing. Under the agreement, …
CeramTec expands German production capacity for orthopaedic ceramics
October 2, 2026CeramTec, Germany, Marktredwitz, orthopaedic ceramics
CeramTec has opened a 12,000m² extension at its Marktredwitz site in Germany, adding around 5,000m² of production space for ceramic …
Migraine annual economic and quality-of-life burden in UK
October 1, 2026AbbVie UK, Health Innovation Manchester, migraine, quality-of-life burden
Migraine affects an estimated 280,000 people across Greater Manchester and creates an annual economic and quality-of-life burden of around £870m, …
bit.bio expands human heart cell portfolio through myriamed partnership
September 30, 2026Biotechnology, bit.bio, drug discovery, myriamed, safety testing
bit.bio has partnered with German biotechnology company myriamed to offer cryopreserved human induced pluripotent stem cell (iPSC)-derived cardiomyocytes for drug …
Phoenix Labs acquires Kent Pharma
September 29, 2026Europe, Ireland, Kent Pharma, Phoenix Labs, acquisition
Phoenix Labs has acquired UK pharmaceutical distributor Kent Pharma from private equity firm Duke Street, expanding its presence in the …
Astoriom acquires Sampled’s UK stability storage operations
September 28, 2026Astoriom, Roylance Scientific, Roylance Stability Storage, Sampled
Astoriom has acquired Roylance Stability Storage and Roylance Scientific, the Glasgow-based UK operations of life sciences stability storage provider Sampled. …
Alcami appoints Will Isom to lead laboratory services sales
September 28, 2026Alcami
Alcami has appointed Will Isom as Vice President of Laboratory Services Sales, creating a new commercial role focused on its …
NIHR chief scientific adviser visits Huddersfield health innovation campus
September 25, 2026Department of Health and Social Care, NHS, National Institute for Health and Care Research, University of Huddersfield
Professor Lucy Chappell, Chief Scientific Adviser to the Department of Health and Social Care and Chief Executive Officer of the …
One in three UK women with migraine say symptoms taken less seriously
September 24, 2026Organon, The Migraine Trust, migraine, symptoms survey
One in three UK women who have experienced migraine say they believe their symptoms are taken less seriously because of …
Report highlights scope to expand day surgery
September 23, 2026Hidden Capacity Report, Mölnlycke Health Care, expanding day surgeries
A new international report from Mölnlycke Health Care has identified opportunities to expand day surgery as healthcare systems face increasing …
Sygnature formalises drug discovery collaboration with X-Chem
September 22, 2026DNA-encoded library screening, Sygnature Discovery, X-Chem, drug discovery collaboration
Sygnature Discovery has established a formal collaboration with drug discovery company X-Chem to integrate DNA-encoded library (DEL) screening into its …
Codis appoints Steven Facer as chief commercial officer
September 21, 2026Codis
Codis has appointed Steven Facer as Chief Commercial Officer (CCO) in a newly created role as the contract development and …
Danish medical cannabis use rises as regulator reports no new safety signals
September 21, 2026Danish Medicines Agency, medical cannabis
Use of medical cannabis increased substantially in Denmark during 2025, while the Danish Medicines Agency reported three suspected adverse-reaction cases …
Equity starts with listening: putting community voices at the centre of access
September 21, 2026Gilead Sciences
This article was developed and funded by Gilead Sciences Ltd. By Peter Wickersham, Vice President and General Manager of Gilead …
Global coalition calls for stronger government action on COPD
September 18, 2026Joint Declaration, Speak Up for COPD coalition, UNITE Parliamentarians Network for Global Health
A global coalition of patient advocates, industry and non-profit organisations has called on governments to strengthen action on chronic obstructive …
Global health researchers call for more equitable partnerships
September 17, 2026Equitable Partnerships in Global Health Research, Global Consortium for Public Health Research, University of Huddersfield, infectious disease, social inequalities
More than 70 academics, researchers, public health professionals, policymakers and research partners from around the world have called for greater …
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026AI, human organoids, infectious disease drug discovery lab, liverpool, robotics
A new £20m high-security laboratory using robotics, artificial intelligence (AI) and human organoids to accelerate drug and vaccine development for …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
